Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis

von Divekar, Anagha A
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2011)